Search

Your search keyword '"Khurshid, Humera"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Khurshid, Humera" Remove constraint Author: "Khurshid, Humera"
37 results on '"Khurshid, Humera"'

Search Results

1. Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

4. NeoRad(Low): A phase 2 trial of neoadjuvant (NA) ipilimumab + nivolumab (ipi+nivo) with low dose stereotactic body radiation therapy (SBRT) as an immune stimulant in patients with resectable stage IB-III non-small cell lung cancer (NSCLC).

6. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

7. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

10. Clinical characteristics, co-mutations and outcomes of advanced non-small cell lung cancer (NSCLC) patients with KRAS mutations.

13. Is there a genomic fingerprint of Radon (Rn)-induced lung cancer (LC)? Comparison of genomic alterations in LC specimens from high and low Rn zones.

14. TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations

16. Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions

17. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

21. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program

23. BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592).

25. Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer

29. Neoadjuvant Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Radiation for Rectal Cancer

30. A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer

31. NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance.

32. Use of Monoclonal Antibodies in Oncology.

33. Shunt nephritis from Propionibacterium acnesin a solitary kidney

34. The Evolving Role of Histology In the Treatment of Non-Small Cell Lung Cancer.

35. Assessment of Frailty and Risk of Chemotherapy Toxicity at a Geriatric-Oncology Multidisciplinary Clinic.

37. TKI-resistant ALK -rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations.

Catalog

Books, media, physical & digital resources